Halberstadt AL

Department of Psychiatry, University of California San Diego, San Diego, CA USA; Research Service, VA San Diego Healthcare System, San Diego, CA USA. Electronic address: ahalberstadt@health.ucsd.edu.

Halberstadt AL

Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.

Correction to "Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights".

Differential Effects of Acute and Chronic Fluoxetine on Psychedelic-Induced Behavior in Mice: Implications for Clinical Trials.

Transforming Amino Acids into Serotonin 5-HT&lt;sub&gt;2A&lt;/sub&gt; Receptor Ligands Using Photochemistry.

Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases.

Discovery of Highly Selective 5-HT&lt;sub&gt;2A&lt;/sub&gt; Agonists Using Structure-Guided Design.

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Visual Hallucinations in Serotonergic Psychedelics and Lewy Body Diseases

Low (micro)doses of 2,5-dimethoxy-4-propylamphetamine (DOPR) increase effortful motivation in low-performing mice.

Analytical and Pharmacological Characterization of 1-(Furan-2-Carbonyl)-LSD (1F-LSD) and Comparison With 1-(Thiophene-2-Carbonyl)-LSD (1T-LSD).

Analytical and behavioral characterization of 1-hexanoyl-LSD (1H-LSD).

Analytical and behavioral characterization of 1-dodecanoyl-LSD (1DD-LSD).

Identification of 5-HT&lt;sub&gt;2A&lt;/sub&gt; receptor signaling pathways associated with psychedelic potential.

Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N<sup>6</sup> -ethylnorlysergic acid N,N-diethylamide (ETH-LAD).

A non-hallucinogenic LSD analog with therapeutic potential for mood disorders.

Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines.

Analytical profile of the lysergamide 1cP-AL-LAD and detection of impurities.

Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD).

(2-Aminopropyl)benzo[β]thiophenes (APBTs) are novel monoamine transporter ligands that lack stimulant effects but display psychedelic-like activity in mice.

Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.

Investigation of the Structure-Activity Relationships of Psilocybin Analogues.

Hallucinations Under Psychedelics and in the Schizophrenia Spectrum: An Interdisciplinary and Multiscale Comparison.

Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ).

Automated detection of the head-twitch response using wavelet scalograms and a deep convolutional neural network.

Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).

Synthesis and Biological Evaluation of Tryptamines Found in Hallucinogenic Mushrooms: Norbaeocystin, Baeocystin, Norpsilocin, and Aeruginascin.

Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).

DARK Classics in Chemical Neuroscience: NBOMes.

Return of the lysergamides. Part V: Analytical and behavioural characterization of 1-butanoyl-d-lysergic acid diethylamide (1B-LSD).

Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.

Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).

Receptor binding profiles and behavioral pharmacology of ring-substituted N,N-diallyltryptamine analogs.

Effect of Hallucinogens on Unconditioned Behavior.

Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).

Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.

Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Serotonergic hallucinogens as translational models relevant to schizophrenia.

Behavioral effects of α,α,β,β-tetradeutero-5-MeO-DMT in rats: comparison with 5-MeO-DMT administered in combination with a monoamine oxidase inhibitor.

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Transforming Amino Acids into Serotonin 5-HT<sub>2A</sub> Receptor Ligands Using Photochemistry.

Discovery of Highly Selective 5-HT<sub>2A</sub> Agonists Using Structure-Guided Design.

Identification of 5-HT<sub>2A</sub> receptor signaling pathways associated with psychedelic potential.